| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetic Foot | 44 | 2026 | 166 | 15.100 |
Why?
|
| Gait | 62 | 2024 | 141 | 12.270 |
Why?
|
| Wearable Electronic Devices | 38 | 2025 | 120 | 12.240 |
Why?
|
| Postural Balance | 46 | 2022 | 134 | 10.580 |
Why?
|
| Frailty | 23 | 2025 | 140 | 9.920 |
Why?
|
| Accidental Falls | 32 | 2022 | 116 | 9.750 |
Why?
|
| Walking | 55 | 2026 | 227 | 7.440 |
Why?
|
| Geriatric Assessment | 32 | 2025 | 183 | 6.730 |
Why?
|
| Frail Elderly | 28 | 2025 | 107 | 6.560 |
Why?
|
| Diabetic Neuropathies | 17 | 2019 | 56 | 6.440 |
Why?
|
| Shoes | 19 | 2026 | 25 | 5.790 |
Why?
|
| Cognitive Dysfunction | 13 | 2025 | 339 | 4.950 |
Why?
|
| Exercise Therapy | 17 | 2022 | 173 | 4.340 |
Why?
|
| Exercise | 26 | 2024 | 863 | 4.020 |
Why?
|
| Aged | 132 | 2025 | 20928 | 4.000 |
Why?
|
| Diabetes Mellitus | 18 | 2024 | 892 | 3.760 |
Why?
|
| Foot Orthoses | 10 | 2024 | 14 | 3.690 |
Why?
|
| Peripheral Nervous System Diseases | 8 | 2021 | 132 | 3.490 |
Why?
|
| Monitoring, Ambulatory | 14 | 2025 | 56 | 3.440 |
Why?
|
| Wound Healing | 22 | 2026 | 482 | 3.150 |
Why?
|
| Monitoring, Physiologic | 11 | 2025 | 369 | 2.930 |
Why?
|
| Activities of Daily Living | 15 | 2024 | 390 | 2.910 |
Why?
|
| Posture | 16 | 2024 | 135 | 2.700 |
Why?
|
| Aged, 80 and over | 54 | 2025 | 6812 | 2.590 |
Why?
|
| Humans | 233 | 2026 | 130496 | 2.470 |
Why?
|
| Foot | 17 | 2024 | 59 | 2.270 |
Why?
|
| Motor Activity | 13 | 2020 | 494 | 2.170 |
Why?
|
| Independent Living | 7 | 2021 | 65 | 2.160 |
Why?
|
| Male | 134 | 2026 | 64498 | 2.110 |
Why?
|
| Female | 136 | 2025 | 70401 | 2.090 |
Why?
|
| Aging | 16 | 2025 | 1244 | 2.080 |
Why?
|
| Middle Aged | 84 | 2026 | 28448 | 2.040 |
Why?
|
| Foot Ulcer | 6 | 2023 | 19 | 1.950 |
Why?
|
| Muscle, Skeletal | 6 | 2026 | 1000 | 1.940 |
Why?
|
| Quality of Life | 18 | 2025 | 2083 | 1.830 |
Why?
|
| Biosensing Techniques | 5 | 2020 | 79 | 1.760 |
Why?
|
| Cognition | 13 | 2025 | 811 | 1.750 |
Why?
|
| Peripheral Arterial Disease | 7 | 2023 | 321 | 1.750 |
Why?
|
| Electric Stimulation Therapy | 7 | 2024 | 88 | 1.700 |
Why?
|
| Fear | 6 | 2023 | 192 | 1.650 |
Why?
|
| Lower Extremity | 6 | 2023 | 183 | 1.640 |
Why?
|
| Ankle Joint | 7 | 2024 | 32 | 1.640 |
Why?
|
| Dementia | 6 | 2022 | 433 | 1.630 |
Why?
|
| Pilot Projects | 22 | 2024 | 1450 | 1.610 |
Why?
|
| Gait Disorders, Neurologic | 8 | 2021 | 47 | 1.610 |
Why?
|
| Movement | 8 | 2021 | 146 | 1.580 |
Why?
|
| Diabetes Complications | 4 | 2024 | 197 | 1.570 |
Why?
|
| Telemedicine | 8 | 2025 | 516 | 1.480 |
Why?
|
| Stress, Physiological | 5 | 2025 | 261 | 1.400 |
Why?
|
| Heart Rate | 9 | 2025 | 576 | 1.380 |
Why?
|
| Computers, Handheld | 2 | 2025 | 33 | 1.360 |
Why?
|
| Stress, Mechanical | 5 | 2024 | 178 | 1.350 |
Why?
|
| Bandages | 8 | 2024 | 52 | 1.330 |
Why?
|
| Feasibility Studies | 13 | 2025 | 812 | 1.330 |
Why?
|
| Weight-Bearing | 7 | 2021 | 44 | 1.320 |
Why?
|
| Upper Extremity | 5 | 2023 | 53 | 1.310 |
Why?
|
| Biomechanical Phenomena | 18 | 2024 | 271 | 1.280 |
Why?
|
| Antineoplastic Agents | 5 | 2021 | 1790 | 1.270 |
Why?
|
| Range of Motion, Articular | 6 | 2017 | 87 | 1.270 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 2 | 2024 | 21 | 1.250 |
Why?
|
| Walking Speed | 6 | 2023 | 18 | 1.240 |
Why?
|
| Diabetes Mellitus, Type 2 | 10 | 2020 | 1438 | 1.180 |
Why?
|
| Parkinson Disease | 7 | 2023 | 726 | 1.170 |
Why?
|
| Veterans | 4 | 2025 | 1788 | 1.170 |
Why?
|
| Oxygen | 2 | 2023 | 551 | 1.170 |
Why?
|
| Accelerometry | 4 | 2020 | 67 | 1.150 |
Why?
|
| Feedback, Sensory | 4 | 2015 | 9 | 1.140 |
Why?
|
| Treatment Outcome | 35 | 2025 | 12850 | 1.090 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 3 | 2025 | 646 | 1.090 |
Why?
|
| Neoplasms | 5 | 2025 | 2955 | 1.080 |
Why?
|
| Speech | 4 | 2024 | 62 | 1.050 |
Why?
|
| Adult | 48 | 2025 | 31183 | 1.040 |
Why?
|
| Pressure | 11 | 2024 | 122 | 1.030 |
Why?
|
| Task Performance and Analysis | 10 | 2020 | 78 | 1.030 |
Why?
|
| Biomarkers | 11 | 2025 | 3388 | 1.020 |
Why?
|
| Thoracic Outlet Syndrome | 3 | 2021 | 20 | 1.010 |
Why?
|
| Orthotic Devices | 3 | 2012 | 20 | 1.000 |
Why?
|
| Surgical Wound Dehiscence | 2 | 2025 | 49 | 0.990 |
Why?
|
| Fasciotomy | 1 | 2026 | 25 | 0.940 |
Why?
|
| Achilles Tendon | 1 | 2026 | 11 | 0.940 |
Why?
|
| Electroacupuncture | 2 | 2016 | 8 | 0.930 |
Why?
|
| Equipment Design | 12 | 2020 | 537 | 0.930 |
Why?
|
| Motor Skills | 5 | 2016 | 74 | 0.910 |
Why?
|
| Pain Management | 4 | 2024 | 205 | 0.900 |
Why?
|
| Self-Help Devices | 2 | 2016 | 10 | 0.900 |
Why?
|
| General Surgery | 2 | 2025 | 225 | 0.900 |
Why?
|
| Proprioception | 3 | 2014 | 17 | 0.880 |
Why?
|
| Fibromyalgia | 1 | 2024 | 19 | 0.870 |
Why?
|
| Casts, Surgical | 2 | 2016 | 21 | 0.860 |
Why?
|
| Fatigue | 3 | 2024 | 193 | 0.860 |
Why?
|
| Muscle Strength | 2 | 2024 | 82 | 0.850 |
Why?
|
| Cross-Over Studies | 2 | 2024 | 322 | 0.820 |
Why?
|
| Cohort Studies | 12 | 2025 | 5081 | 0.820 |
Why?
|
| Renal Dialysis | 5 | 2024 | 948 | 0.820 |
Why?
|
| Molecular Dynamics Simulation | 4 | 2014 | 125 | 0.820 |
Why?
|
| Scoliosis | 2 | 2015 | 152 | 0.810 |
Why?
|
| Stroke | 8 | 2021 | 1055 | 0.790 |
Why?
|
| Postoperative Care | 2 | 2025 | 295 | 0.790 |
Why?
|
| Thorax | 3 | 2019 | 65 | 0.780 |
Why?
|
| Mammaplasty | 1 | 2023 | 44 | 0.770 |
Why?
|
| Sensation Disorders | 3 | 2016 | 25 | 0.750 |
Why?
|
| Resilience, Psychological | 1 | 2024 | 79 | 0.750 |
Why?
|
| Primary Prevention | 2 | 2013 | 177 | 0.730 |
Why?
|
| Algorithms | 11 | 2020 | 1678 | 0.720 |
Why?
|
| Patient Participation | 1 | 2025 | 247 | 0.720 |
Why?
|
| Breast | 1 | 2023 | 214 | 0.720 |
Why?
|
| Low Back Pain | 3 | 2018 | 40 | 0.720 |
Why?
|
| Reproducibility of Results | 15 | 2026 | 2908 | 0.710 |
Why?
|
| Case-Control Studies | 11 | 2021 | 3380 | 0.700 |
Why?
|
| Workplace | 2 | 2019 | 83 | 0.700 |
Why?
|
| Clinical Competence | 4 | 2025 | 1062 | 0.690 |
Why?
|
| Pain | 5 | 2024 | 429 | 0.690 |
Why?
|
| Double-Blind Method | 7 | 2024 | 1628 | 0.690 |
Why?
|
| Foot Deformities | 2 | 2012 | 4 | 0.680 |
Why?
|
| Remote Sensing Technology | 1 | 2021 | 4 | 0.680 |
Why?
|
| Risk Factors | 18 | 2025 | 10959 | 0.680 |
Why?
|
| Flavonoids | 1 | 2022 | 83 | 0.680 |
Why?
|
| Platelet-Rich Plasma | 1 | 2021 | 23 | 0.680 |
Why?
|
| Acceleration | 5 | 2023 | 26 | 0.650 |
Why?
|
| Clothing | 2 | 2017 | 11 | 0.650 |
Why?
|
| Occupational Health | 2 | 2019 | 47 | 0.640 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2023 | 245 | 0.640 |
Why?
|
| Cancer Survivors | 2 | 2021 | 272 | 0.640 |
Why?
|
| Cicatrix | 1 | 2021 | 124 | 0.640 |
Why?
|
| Human Activities | 1 | 2020 | 8 | 0.630 |
Why?
|
| Water | 2 | 2012 | 185 | 0.630 |
Why?
|
| Physical Examination | 1 | 2021 | 164 | 0.620 |
Why?
|
| Laparoscopy | 1 | 2025 | 540 | 0.620 |
Why?
|
| Humidity | 1 | 2019 | 25 | 0.620 |
Why?
|
| Wounds and Injuries | 4 | 2024 | 391 | 0.610 |
Why?
|
| Sternotomy | 1 | 2019 | 42 | 0.600 |
Why?
|
| Follow-Up Studies | 13 | 2025 | 5177 | 0.600 |
Why?
|
| User-Computer Interface | 3 | 2015 | 164 | 0.590 |
Why?
|
| Ankle | 4 | 2024 | 29 | 0.590 |
Why?
|
| Physical Stimulation | 1 | 2019 | 37 | 0.590 |
Why?
|
| Pain Measurement | 4 | 2024 | 348 | 0.580 |
Why?
|
| Interior Design and Furnishings | 1 | 2018 | 4 | 0.570 |
Why?
|
| Diabetes Mellitus, Type 1 | 5 | 2023 | 879 | 0.570 |
Why?
|
| Healthy Aging | 1 | 2018 | 13 | 0.560 |
Why?
|
| Electric Stimulation | 4 | 2023 | 237 | 0.560 |
Why?
|
| Shoulder | 2 | 2015 | 31 | 0.560 |
Why?
|
| Trail Making Test | 2 | 2021 | 6 | 0.550 |
Why?
|
| Feedback, Physiological | 2 | 2016 | 66 | 0.550 |
Why?
|
| Osteoarthritis, Knee | 1 | 2021 | 277 | 0.540 |
Why?
|
| Kidney Failure, Chronic | 2 | 2023 | 939 | 0.540 |
Why?
|
| Prospective Studies | 10 | 2024 | 6451 | 0.540 |
Why?
|
| Femoral Vein | 1 | 2017 | 43 | 0.540 |
Why?
|
| Actigraphy | 1 | 2017 | 52 | 0.530 |
Why?
|
| Thermometers | 1 | 2017 | 9 | 0.520 |
Why?
|
| Depression | 3 | 2022 | 1317 | 0.520 |
Why?
|
| Hallux Valgus | 2 | 2014 | 2 | 0.520 |
Why?
|
| Suicide | 1 | 2020 | 204 | 0.520 |
Why?
|
| Somatosensory Disorders | 1 | 2017 | 4 | 0.520 |
Why?
|
| Wireless Technology | 1 | 2017 | 12 | 0.520 |
Why?
|
| Fiber Optic Technology | 1 | 2017 | 44 | 0.520 |
Why?
|
| Personal Autonomy | 1 | 2018 | 206 | 0.510 |
Why?
|
| Polysomnography | 1 | 2017 | 154 | 0.490 |
Why?
|
| DNA | 1 | 2022 | 1407 | 0.490 |
Why?
|
| Video Games | 1 | 2017 | 96 | 0.490 |
Why?
|
| Vascular Surgical Procedures | 2 | 2020 | 535 | 0.480 |
Why?
|
| Disability Evaluation | 3 | 2018 | 189 | 0.480 |
Why?
|
| Venous Thrombosis | 1 | 2017 | 163 | 0.480 |
Why?
|
| Equipment Failure Analysis | 3 | 2012 | 79 | 0.470 |
Why?
|
| Intervertebral Disc Displacement | 1 | 2015 | 20 | 0.470 |
Why?
|
| Fasciitis, Plantar | 1 | 2015 | 1 | 0.460 |
Why?
|
| Heel | 1 | 2015 | 9 | 0.450 |
Why?
|
| Spinal Stenosis | 1 | 2015 | 10 | 0.450 |
Why?
|
| Skating | 1 | 2015 | 1 | 0.450 |
Why?
|
| Forearm | 1 | 2015 | 39 | 0.450 |
Why?
|
| Severity of Illness Index | 8 | 2025 | 3041 | 0.450 |
Why?
|
| Internship and Residency | 1 | 2025 | 1219 | 0.450 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 364 | 0.450 |
Why?
|
| Autonomic Nervous System | 1 | 2015 | 48 | 0.450 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 376 | 0.440 |
Why?
|
| Machine Learning | 4 | 2023 | 383 | 0.440 |
Why?
|
| ROC Curve | 3 | 2025 | 612 | 0.440 |
Why?
|
| Flatfoot | 1 | 2014 | 2 | 0.440 |
Why?
|
| Mobility Limitation | 2 | 2016 | 32 | 0.440 |
Why?
|
| Electromyography | 3 | 2024 | 135 | 0.440 |
Why?
|
| Wrist | 3 | 2021 | 27 | 0.440 |
Why?
|
| Sleep Wake Disorders | 1 | 2017 | 203 | 0.440 |
Why?
|
| Limb Salvage | 4 | 2023 | 152 | 0.430 |
Why?
|
| Visual Perception | 2 | 2014 | 127 | 0.430 |
Why?
|
| Sleep | 4 | 2021 | 366 | 0.430 |
Why?
|
| Walkers | 2 | 2023 | 3 | 0.420 |
Why?
|
| Virtual Reality Exposure Therapy | 1 | 2013 | 3 | 0.410 |
Why?
|
| Podiatry | 1 | 2013 | 7 | 0.410 |
Why?
|
| Signal Processing, Computer-Assisted | 4 | 2017 | 119 | 0.410 |
Why?
|
| Automobile Driving | 1 | 2014 | 29 | 0.400 |
Why?
|
| Risk Assessment | 8 | 2024 | 3680 | 0.400 |
Why?
|
| Affect | 1 | 2014 | 162 | 0.400 |
Why?
|
| Hypesthesia | 2 | 2023 | 10 | 0.400 |
Why?
|
| Osteotomy | 1 | 2013 | 45 | 0.400 |
Why?
|
| Surveys and Questionnaires | 4 | 2025 | 4023 | 0.380 |
Why?
|
| Graphite | 1 | 2012 | 16 | 0.380 |
Why?
|
| Durable Medical Equipment | 1 | 2012 | 4 | 0.370 |
Why?
|
| Time and Motion Studies | 2 | 2022 | 16 | 0.370 |
Why?
|
| Ribs | 3 | 2021 | 53 | 0.370 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2012 | 7 | 0.370 |
Why?
|
| Nanostructures | 1 | 2012 | 65 | 0.370 |
Why?
|
| Attention | 6 | 2020 | 195 | 0.370 |
Why?
|
| Equipment and Supplies | 1 | 2012 | 28 | 0.360 |
Why?
|
| Stroke Rehabilitation | 3 | 2021 | 65 | 0.360 |
Why?
|
| Geriatrics | 3 | 2018 | 74 | 0.360 |
Why?
|
| Time Factors | 10 | 2022 | 6206 | 0.350 |
Why?
|
| Movement Disorders | 2 | 2014 | 220 | 0.350 |
Why?
|
| Skin | 3 | 2021 | 540 | 0.350 |
Why?
|
| Cross-Sectional Studies | 9 | 2023 | 3807 | 0.340 |
Why?
|
| Perfusion | 2 | 2023 | 211 | 0.340 |
Why?
|
| Age Factors | 7 | 2016 | 2839 | 0.330 |
Why?
|
| Healthy Volunteers | 3 | 2024 | 151 | 0.330 |
Why?
|
| Sensitivity and Specificity | 7 | 2023 | 2105 | 0.330 |
Why?
|
| Hip Joint | 3 | 2015 | 47 | 0.320 |
Why?
|
| Arthropathy, Neurogenic | 1 | 2010 | 3 | 0.320 |
Why?
|
| Running | 1 | 2010 | 32 | 0.310 |
Why?
|
| Ischemia | 3 | 2023 | 358 | 0.310 |
Why?
|
| Carbon Monoxide | 1 | 2009 | 26 | 0.300 |
Why?
|
| Decompression, Surgical | 4 | 2021 | 84 | 0.300 |
Why?
|
| Tibia | 1 | 2010 | 87 | 0.300 |
Why?
|
| Chronic Pain | 2 | 2024 | 161 | 0.300 |
Why?
|
| Predictive Value of Tests | 5 | 2018 | 2300 | 0.300 |
Why?
|
| Analysis of Variance | 4 | 2016 | 938 | 0.290 |
Why?
|
| Alzheimer Disease | 1 | 2016 | 879 | 0.290 |
Why?
|
| Patient Satisfaction | 3 | 2018 | 460 | 0.290 |
Why?
|
| Blood Glucose Self-Monitoring | 3 | 2024 | 130 | 0.280 |
Why?
|
| Linear Models | 3 | 2015 | 687 | 0.270 |
Why?
|
| Disease Management | 2 | 2024 | 556 | 0.270 |
Why?
|
| Surgeons | 3 | 2024 | 288 | 0.270 |
Why?
|
| Body Mass Index | 5 | 2021 | 1679 | 0.270 |
Why?
|
| Postoperative Complications | 1 | 2019 | 3110 | 0.260 |
Why?
|
| Textiles | 2 | 2017 | 10 | 0.260 |
Why?
|
| Ambulatory Care Facilities | 2 | 2022 | 233 | 0.260 |
Why?
|
| Bone Density | 1 | 2010 | 366 | 0.260 |
Why?
|
| Young Adult | 8 | 2021 | 10010 | 0.250 |
Why?
|
| Joints | 3 | 2012 | 26 | 0.250 |
Why?
|
| Chronic Disease | 5 | 2024 | 1236 | 0.250 |
Why?
|
| Magnesium Compounds | 1 | 2006 | 1 | 0.250 |
Why?
|
| Magnesium Silicates | 1 | 2006 | 1 | 0.250 |
Why?
|
| Silicon Compounds | 1 | 2006 | 1 | 0.250 |
Why?
|
| Insulin Infusion Systems | 2 | 2024 | 67 | 0.250 |
Why?
|
| Calcium Carbonate | 1 | 2006 | 11 | 0.250 |
Why?
|
| Logistic Models | 3 | 2016 | 1811 | 0.250 |
Why?
|
| Oxyhemoglobins | 2 | 2024 | 25 | 0.250 |
Why?
|
| Phenotype | 3 | 2021 | 4479 | 0.250 |
Why?
|
| Cadmium | 1 | 2006 | 33 | 0.240 |
Why?
|
| Equinus Deformity | 1 | 2026 | 2 | 0.240 |
Why?
|
| Tenotomy | 1 | 2026 | 5 | 0.240 |
Why?
|
| Patient Compliance | 3 | 2018 | 461 | 0.240 |
Why?
|
| Telerehabilitation | 1 | 2025 | 10 | 0.240 |
Why?
|
| Retinal Artery Occlusion | 1 | 2026 | 15 | 0.240 |
Why?
|
| Incidence | 6 | 2025 | 3327 | 0.240 |
Why?
|
| Patient Reported Outcome Measures | 3 | 2024 | 222 | 0.230 |
Why?
|
| Recovery of Function | 3 | 2018 | 448 | 0.230 |
Why?
|
| Body Temperature | 3 | 2017 | 126 | 0.230 |
Why?
|
| Artificial Intelligence | 3 | 2024 | 354 | 0.230 |
Why?
|
| Arizona | 2 | 2015 | 25 | 0.230 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2026 | 103 | 0.230 |
Why?
|
| Osteomyelitis | 2 | 2025 | 210 | 0.220 |
Why?
|
| Integrative Medicine | 2 | 2015 | 15 | 0.220 |
Why?
|
| Retrospective Studies | 11 | 2025 | 17554 | 0.220 |
Why?
|
| Inpatients | 3 | 2021 | 559 | 0.210 |
Why?
|
| Hydrocortisone | 1 | 2025 | 212 | 0.210 |
Why?
|
| Ergonomics | 1 | 2024 | 24 | 0.210 |
Why?
|
| Endocarditis | 1 | 2025 | 103 | 0.210 |
Why?
|
| Spinal Fusion | 2 | 2015 | 125 | 0.210 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2024 | 23 | 0.210 |
Why?
|
| Endocarditis, Bacterial | 1 | 2025 | 128 | 0.200 |
Why?
|
| Role | 2 | 2013 | 27 | 0.200 |
Why?
|
| Single-Blind Method | 4 | 2023 | 236 | 0.200 |
Why?
|
| Operating Rooms | 1 | 2024 | 74 | 0.200 |
Why?
|
| Diffusion | 1 | 2023 | 57 | 0.200 |
Why?
|
| Supranuclear Palsy, Progressive | 1 | 2023 | 29 | 0.200 |
Why?
|
| Video Recording | 1 | 2025 | 207 | 0.200 |
Why?
|
| Information Dissemination | 1 | 2026 | 195 | 0.200 |
Why?
|
| Hypertrophy | 1 | 2023 | 99 | 0.200 |
Why?
|
| Pandemics | 2 | 2021 | 1159 | 0.190 |
Why?
|
| Early Ambulation | 1 | 2022 | 8 | 0.190 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2020 | 500 | 0.190 |
Why?
|
| Anthropometry | 2 | 2013 | 187 | 0.190 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2024 | 157 | 0.190 |
Why?
|
| Stress, Psychological | 2 | 2018 | 539 | 0.190 |
Why?
|
| Pyrimidines | 1 | 2026 | 452 | 0.180 |
Why?
|
| Bandages, Hydrocolloid | 1 | 2022 | 2 | 0.180 |
Why?
|
| Immunosenescence | 1 | 2022 | 4 | 0.180 |
Why?
|
| Physical and Rehabilitation Medicine | 1 | 2002 | 28 | 0.180 |
Why?
|
| Albumins | 1 | 2022 | 87 | 0.180 |
Why?
|
| Cerebellar Ataxia | 1 | 2022 | 62 | 0.180 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2024 | 230 | 0.180 |
Why?
|
| Molecular Structure | 3 | 2012 | 314 | 0.180 |
Why?
|
| Neuropsychological Tests | 2 | 2022 | 956 | 0.180 |
Why?
|
| Swine | 1 | 2025 | 1185 | 0.180 |
Why?
|
| Hospitalization | 4 | 2025 | 1929 | 0.180 |
Why?
|
| Glomerular Filtration Rate | 1 | 2025 | 568 | 0.180 |
Why?
|
| Re-Epithelialization | 1 | 2021 | 15 | 0.180 |
Why?
|
| Sensation | 2 | 2023 | 48 | 0.170 |
Why?
|
| Injections, Intra-Articular | 1 | 2021 | 32 | 0.170 |
Why?
|
| Foot Diseases | 2 | 2020 | 20 | 0.170 |
Why?
|
| Parkinsonian Disorders | 1 | 2022 | 77 | 0.170 |
Why?
|
| Molecular Docking Simulation | 1 | 2022 | 150 | 0.170 |
Why?
|
| Aggression | 1 | 2023 | 218 | 0.170 |
Why?
|
| Triage | 1 | 2022 | 143 | 0.170 |
Why?
|
| Neurosurgical Procedures | 1 | 2024 | 320 | 0.170 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2022 | 152 | 0.170 |
Why?
|
| Biofeedback, Psychology | 2 | 2017 | 38 | 0.170 |
Why?
|
| Thrombosis | 1 | 2026 | 493 | 0.170 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2026 | 613 | 0.170 |
Why?
|
| Bacteremia | 1 | 2025 | 428 | 0.170 |
Why?
|
| Ecosystem | 1 | 2021 | 90 | 0.160 |
Why?
|
| Ligands | 1 | 2022 | 486 | 0.160 |
Why?
|
| Communication | 1 | 2025 | 536 | 0.160 |
Why?
|
| Hyaluronic Acid | 1 | 2021 | 108 | 0.160 |
Why?
|
| Gangrene | 1 | 2020 | 26 | 0.160 |
Why?
|
| Morphine | 1 | 2020 | 80 | 0.160 |
Why?
|
| Leukocytes | 1 | 2021 | 208 | 0.160 |
Why?
|
| Robotic Surgical Procedures | 2 | 2021 | 223 | 0.160 |
Why?
|
| Diffusion of Innovation | 1 | 2020 | 84 | 0.150 |
Why?
|
| Biomedical Research | 1 | 2026 | 561 | 0.150 |
Why?
|
| Staphylococcal Infections | 1 | 2024 | 563 | 0.150 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2025 | 1268 | 0.150 |
Why?
|
| Wakefulness | 1 | 2020 | 103 | 0.150 |
Why?
|
| Schools | 1 | 2021 | 236 | 0.150 |
Why?
|
| Tissue Engineering | 2 | 2018 | 153 | 0.150 |
Why?
|
| Vibration | 1 | 2019 | 30 | 0.150 |
Why?
|
| Remission Induction | 1 | 2020 | 303 | 0.150 |
Why?
|
| Touch Perception | 1 | 2019 | 22 | 0.140 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2020 | 106 | 0.140 |
Why?
|
| Health Personnel | 1 | 2024 | 549 | 0.140 |
Why?
|
| Communicable Disease Control | 1 | 2020 | 141 | 0.140 |
Why?
|
| Weight Gain | 1 | 2021 | 382 | 0.140 |
Why?
|
| Anesthesia, Spinal | 1 | 2018 | 13 | 0.140 |
Why?
|
| Ankle Brachial Index | 2 | 2015 | 40 | 0.140 |
Why?
|
| Information Technology | 1 | 2018 | 9 | 0.140 |
Why?
|
| Educational Measurement | 1 | 2021 | 317 | 0.140 |
Why?
|
| Virtual Reality | 1 | 2018 | 35 | 0.140 |
Why?
|
| Exoskeleton Device | 1 | 2017 | 4 | 0.130 |
Why?
|
| Environment | 1 | 2018 | 149 | 0.130 |
Why?
|
| Psychiatry | 1 | 2021 | 269 | 0.130 |
Why?
|
| Nerve Block | 1 | 2018 | 68 | 0.130 |
Why?
|
| HIV Infections | 2 | 2022 | 2037 | 0.130 |
Why?
|
| Regional Blood Flow | 1 | 2017 | 191 | 0.130 |
Why?
|
| Protective Devices | 1 | 2017 | 8 | 0.130 |
Why?
|
| Prognosis | 3 | 2023 | 4880 | 0.130 |
Why?
|
| Models, Statistical | 1 | 2020 | 483 | 0.130 |
Why?
|
| Knee Joint | 2 | 2010 | 171 | 0.130 |
Why?
|
| Walk Test | 1 | 2017 | 27 | 0.130 |
Why?
|
| Osteoarthritis, Spine | 1 | 2016 | 2 | 0.130 |
Why?
|
| Quality of Health Care | 1 | 2020 | 409 | 0.130 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2018 | 152 | 0.130 |
Why?
|
| Ultrasonography, Doppler | 1 | 2017 | 185 | 0.130 |
Why?
|
| Proof of Concept Study | 1 | 2016 | 42 | 0.130 |
Why?
|
| Amnesia | 1 | 2016 | 20 | 0.120 |
Why?
|
| Caregivers | 1 | 2022 | 574 | 0.120 |
Why?
|
| Blood Flow Velocity | 1 | 2017 | 418 | 0.120 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 1123 | 0.120 |
Why?
|
| Escherichia coli | 1 | 2022 | 992 | 0.120 |
Why?
|
| Physical Therapy Modalities | 1 | 2016 | 52 | 0.120 |
Why?
|
| Medical Staff, Hospital | 1 | 2016 | 94 | 0.120 |
Why?
|
| Torso | 1 | 2015 | 13 | 0.120 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2018 | 253 | 0.120 |
Why?
|
| Patient Discharge | 2 | 2016 | 511 | 0.120 |
Why?
|
| Anesthetics, Local | 1 | 2016 | 85 | 0.120 |
Why?
|
| False Positive Reactions | 1 | 2015 | 143 | 0.120 |
Why?
|
| Varicose Ulcer | 1 | 2015 | 2 | 0.110 |
Why?
|
| Hip | 1 | 2015 | 19 | 0.110 |
Why?
|
| Hand Strength | 1 | 2015 | 56 | 0.110 |
Why?
|
| House Calls | 1 | 2015 | 35 | 0.110 |
Why?
|
| Trauma Centers | 1 | 2016 | 205 | 0.110 |
Why?
|
| Gastric Bypass | 1 | 2016 | 96 | 0.110 |
Why?
|
| Islet Amyloid Polypeptide | 1 | 2014 | 13 | 0.110 |
Why?
|
| Internet | 1 | 2018 | 420 | 0.110 |
Why?
|
| Gravitation | 1 | 2014 | 11 | 0.110 |
Why?
|
| Lipid Bilayers | 1 | 2014 | 44 | 0.110 |
Why?
|
| Transducers | 3 | 2003 | 22 | 0.110 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2023 | 1156 | 0.110 |
Why?
|
| Eye Movements | 1 | 2014 | 68 | 0.110 |
Why?
|
| Glucocorticoids | 1 | 2016 | 343 | 0.110 |
Why?
|
| Physical Fitness | 2 | 2014 | 90 | 0.100 |
Why?
|
| Resistance Training | 1 | 2014 | 26 | 0.100 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 694 | 0.100 |
Why?
|
| Tai Ji | 1 | 2014 | 8 | 0.100 |
Why?
|
| Blood Glucose | 3 | 2024 | 1110 | 0.100 |
Why?
|
| Skin Transplantation | 1 | 2014 | 56 | 0.100 |
Why?
|
| Risk | 1 | 2015 | 725 | 0.100 |
Why?
|
| Adaptation, Physiological | 1 | 2015 | 259 | 0.100 |
Why?
|
| Residence Characteristics | 1 | 2016 | 291 | 0.100 |
Why?
|
| Preoperative Period | 1 | 2013 | 90 | 0.100 |
Why?
|
| Obesity, Morbid | 1 | 2016 | 230 | 0.100 |
Why?
|
| Touch | 1 | 2013 | 38 | 0.100 |
Why?
|
| Leg | 2 | 2012 | 119 | 0.100 |
Why?
|
| Body Weight | 1 | 2017 | 987 | 0.100 |
Why?
|
| Community Networks | 1 | 2012 | 30 | 0.090 |
Why?
|
| Risk Reduction Behavior | 1 | 2013 | 142 | 0.090 |
Why?
|
| Anisotropy | 1 | 2012 | 117 | 0.090 |
Why?
|
| Postoperative Period | 1 | 2013 | 330 | 0.090 |
Why?
|
| Stockings, Compression | 1 | 2012 | 1 | 0.090 |
Why?
|
| Teaching | 1 | 2014 | 197 | 0.090 |
Why?
|
| Models, Theoretical | 1 | 2014 | 362 | 0.090 |
Why?
|
| Neural Prostheses | 1 | 2012 | 4 | 0.090 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2020 | 746 | 0.090 |
Why?
|
| Weight Loss | 1 | 2016 | 531 | 0.090 |
Why?
|
| Radiography | 2 | 2014 | 742 | 0.090 |
Why?
|
| Clinical Decision-Making | 1 | 2014 | 310 | 0.090 |
Why?
|
| Precision Medicine | 1 | 2015 | 381 | 0.090 |
Why?
|
| Prosthesis Design | 1 | 2014 | 618 | 0.090 |
Why?
|
| Endovascular Procedures | 1 | 2020 | 778 | 0.090 |
Why?
|
| Hand | 2 | 2023 | 94 | 0.090 |
Why?
|
| United States | 3 | 2026 | 11877 | 0.090 |
Why?
|
| Child | 4 | 2023 | 26100 | 0.090 |
Why?
|
| Electrocardiography | 1 | 2017 | 973 | 0.090 |
Why?
|
| Ionic Liquids | 1 | 2011 | 4 | 0.090 |
Why?
|
| Organophosphorus Compounds | 1 | 2011 | 26 | 0.090 |
Why?
|
| Edema | 1 | 2012 | 134 | 0.080 |
Why?
|
| Self Concept | 1 | 2012 | 158 | 0.080 |
Why?
|
| Statistics, Nonparametric | 2 | 2010 | 425 | 0.080 |
Why?
|
| Motion | 2 | 2023 | 37 | 0.080 |
Why?
|
| Glycation End Products, Advanced | 1 | 2010 | 26 | 0.080 |
Why?
|
| Tendons | 1 | 2010 | 33 | 0.080 |
Why?
|
| Adolescent | 4 | 2021 | 20739 | 0.080 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 1377 | 0.080 |
Why?
|
| Physical Exertion | 1 | 2010 | 63 | 0.080 |
Why?
|
| Mutation, Missense | 1 | 2014 | 929 | 0.080 |
Why?
|
| Health Promotion | 1 | 2013 | 411 | 0.080 |
Why?
|
| Locomotion | 1 | 2010 | 59 | 0.080 |
Why?
|
| Sex Factors | 1 | 2013 | 1343 | 0.080 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2010 | 70 | 0.080 |
Why?
|
| Vision, Ocular | 1 | 2010 | 120 | 0.070 |
Why?
|
| Health Services for the Aged | 2 | 2014 | 33 | 0.070 |
Why?
|
| Hypoglycemic Agents | 2 | 2024 | 478 | 0.070 |
Why?
|
| Carbon Isotopes | 1 | 2009 | 228 | 0.070 |
Why?
|
| Oxygen Consumption | 1 | 2010 | 298 | 0.070 |
Why?
|
| Lung | 1 | 2017 | 1547 | 0.070 |
Why?
|
| Insulin | 2 | 2024 | 1140 | 0.070 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2009 | 256 | 0.070 |
Why?
|
| Amino Acids | 1 | 2011 | 562 | 0.070 |
Why?
|
| Bone and Bones | 1 | 2010 | 307 | 0.070 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2008 | 89 | 0.070 |
Why?
|
| Adipose Tissue | 1 | 2010 | 494 | 0.060 |
Why?
|
| Models, Biological | 2 | 2002 | 1386 | 0.060 |
Why?
|
| Survivors | 2 | 2021 | 344 | 0.060 |
Why?
|
| Anterior Cruciate Ligament | 1 | 2006 | 11 | 0.060 |
Why?
|
| Retinal Artery | 1 | 2026 | 16 | 0.060 |
Why?
|
| Thermodynamics | 1 | 2006 | 145 | 0.060 |
Why?
|
| Mass Screening | 1 | 2012 | 814 | 0.060 |
Why?
|
| Dasatinib | 1 | 2026 | 51 | 0.060 |
Why?
|
| Animals | 2 | 2025 | 33855 | 0.060 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2026 | 136 | 0.060 |
Why?
|
| Psychomotor Performance | 1 | 2006 | 170 | 0.060 |
Why?
|
| Debridement | 1 | 2025 | 87 | 0.050 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2004 | 74 | 0.050 |
Why?
|
| Ulcer | 1 | 2023 | 51 | 0.050 |
Why?
|
| Dysarthria | 1 | 2023 | 25 | 0.050 |
Why?
|
| Osteoarthritis, Hip | 1 | 2004 | 61 | 0.050 |
Why?
|
| Exudates and Transudates | 1 | 2023 | 15 | 0.050 |
Why?
|
| Soft Tissue Infections | 1 | 2024 | 89 | 0.050 |
Why?
|
| Software | 1 | 2008 | 735 | 0.050 |
Why?
|
| Rotation | 1 | 2003 | 34 | 0.050 |
Why?
|
| Neurosurgery | 1 | 2024 | 69 | 0.050 |
Why?
|
| Prone Position | 1 | 2003 | 32 | 0.050 |
Why?
|
| Metatarsal Bones | 1 | 2022 | 7 | 0.050 |
Why?
|
| Endpoint Determination | 1 | 2023 | 55 | 0.050 |
Why?
|
| Anastomosis, Surgical | 1 | 2023 | 176 | 0.050 |
Why?
|
| Technology | 1 | 2023 | 68 | 0.050 |
Why?
|
| Diagnostic Equipment | 1 | 2002 | 1 | 0.050 |
Why?
|
| Surgical Wound Infection | 1 | 2025 | 265 | 0.050 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2022 | 32 | 0.050 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2004 | 111 | 0.050 |
Why?
|
| Self Care | 1 | 2023 | 228 | 0.040 |
Why?
|
| CD28 Antigens | 1 | 2022 | 76 | 0.040 |
Why?
|
| Goals | 1 | 2022 | 124 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2023 | 265 | 0.040 |
Why?
|
| Verbal Behavior | 3 | 2007 | 44 | 0.040 |
Why?
|
| Ataxia | 1 | 2022 | 157 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2025 | 1488 | 0.040 |
Why?
|
| Dissection | 1 | 2020 | 57 | 0.040 |
Why?
|
| Research Design | 2 | 2015 | 715 | 0.040 |
Why?
|
| Self Report | 1 | 2023 | 555 | 0.040 |
Why?
|
| Seasons | 1 | 2021 | 332 | 0.040 |
Why?
|
| Reaction Time | 1 | 2020 | 156 | 0.040 |
Why?
|
| Patient Selection | 1 | 2023 | 720 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 465 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2022 | 499 | 0.040 |
Why?
|
| Neuroimaging | 1 | 2022 | 383 | 0.040 |
Why?
|
| Fitness Trackers | 1 | 2018 | 15 | 0.030 |
Why?
|
| Regenerative Medicine | 1 | 2018 | 37 | 0.030 |
Why?
|
| Healthcare Disparities | 1 | 2023 | 510 | 0.030 |
Why?
|
| Europe | 1 | 2018 | 366 | 0.030 |
Why?
|
| Triamcinolone | 1 | 2016 | 12 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2024 | 817 | 0.030 |
Why?
|
| Lidocaine | 1 | 2016 | 39 | 0.030 |
Why?
|
| Injections, Spinal | 1 | 2016 | 129 | 0.030 |
Why?
|
| Bupivacaine | 1 | 2016 | 26 | 0.030 |
Why?
|
| Exercise Tolerance | 1 | 2017 | 91 | 0.030 |
Why?
|
| Home Care Services | 1 | 2017 | 69 | 0.030 |
Why?
|
| Sweat | 1 | 2015 | 6 | 0.030 |
Why?
|
| Patient Care Management | 1 | 2016 | 61 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2018 | 548 | 0.030 |
Why?
|
| Skin, Artificial | 1 | 2015 | 7 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 483 | 0.030 |
Why?
|
| Smartphone | 1 | 2015 | 46 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2018 | 796 | 0.030 |
Why?
|
| Orthopedic Procedures | 1 | 2014 | 81 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2014 | 189 | 0.020 |
Why?
|
| Sarcopenia | 1 | 2014 | 55 | 0.020 |
Why?
|
| Immunity | 1 | 2014 | 180 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2025 | 2564 | 0.020 |
Why?
|
| Reference Standards | 2 | 2003 | 233 | 0.020 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2015 | 472 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 2406 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2021 | 14946 | 0.020 |
Why?
|
| Finite Element Analysis | 1 | 2010 | 38 | 0.020 |
Why?
|
| Prednisolone | 1 | 2010 | 71 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2014 | 832 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 3487 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2012 | 654 | 0.020 |
Why?
|
| Disease Progression | 1 | 2016 | 2204 | 0.020 |
Why?
|
| Endocrinology | 1 | 2012 | 126 | 0.020 |
Why?
|
| Mitochondria | 1 | 2014 | 775 | 0.020 |
Why?
|
| Cytokines | 1 | 2014 | 1342 | 0.020 |
Why?
|
| Apoptosis | 1 | 2014 | 1832 | 0.020 |
Why?
|
| Anterior Cruciate Ligament Injuries | 1 | 2006 | 28 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 4669 | 0.010 |
Why?
|
| Spinal Cord | 1 | 2004 | 259 | 0.010 |
Why?
|